• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by KB Financial Group Inc

    7/31/24 6:07:50 AM ET
    $KB
    Commercial Banks
    Finance
    Get the next $KB alert in real time by email
    6-K 1 d835647d6k.htm FORM 6-K Form 6-K

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    Form 6-K

     

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    For the month of July 2024

    Commission File Number: 000-53445

     

     

    KB Financial Group Inc.

    (Translation of registrant’s name into English)

     

     

    26, Gukjegeumyung-ro 8-gil, Yeongdeungpo-gu, Seoul 07331, Korea

    (Address of principal executive office)

     

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

    Form 20-F ☒    Form 40-F ☐

     

     

     


    Termination of Trust Agreement for Acquisition of Treasury Shares

    KB Financial Group Inc. (“KB Financial Group”) announced on July 31, 2024 that the trust agreement it had entered into on August 1, 2023 (the “Trust Agreement”) to acquire treasury shares has been terminated.

     

    Total Contract Amount (KRW)    Before Termination    300,000,000,000
       After Termination    0
    Contract Period (Before Termination)    Effective Date    August 1, 2023
       Termination Date    July 31, 2024
    Reason for Termination    Expiration of the term of the Trust Agreement
    Counterparty    Samsung Securities Co., Ltd.
    Expected Date of Termination    July 31, 2024
    Method of Return of Trust Properties upon Termination    Return of cash and treasury shares
    Number of Treasury Shares Held Prior to Termination    Acquisitions from Profits Available for Dividend    Common Shares (percentage)    24,245,382 shares (6.01%)
       Other Shares    —
       Other Acquisitions    Common Shares (percentage)    —
       Other Shares    —
       
    Date of Resolution by the Board of Directors    —
       
    Other Matters to Consider Before Making an Investment Decision   

    •  Pursuant to Article 176-2 of the Enforcement Decree of the Financial Investment Services and Capital Markets Act of Korea, no separate resolution of the board of directors is required as the trust agreement is being terminated upon the expiration of the term of the Trust Agreement.

     

    •  The number of treasury shares acquired upon termination of the Trust Agreement is 5,584,514, which will be kept in KB Financial Group’s corporate account.

     

    •  The total number of treasury shares held by KB Financial Group prior to the termination of the Trust Agreement (as of July 31, 2024) is 24,245,382.


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

       

    KB Financial Group Inc.

        (Registrant)
    Date: July 31, 2024    

    By: /s/ Jae Kwan Kim

        (Signature)
        Name: Jae Kwan Kim
        Title: Senior Executive Vice President and Chief Finance Officer
    Get the next $KB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $KB

    DatePrice TargetRatingAnalyst
    12/12/2024Equal-Weight → Overweight
    Morgan Stanley
    10/5/2023Outperform → Buy
    CLSA
    More analyst ratings

    $KB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    KB Financial upgraded by Morgan Stanley

    Morgan Stanley upgraded KB Financial from Equal-Weight to Overweight

    12/12/24 1:55:07 PM ET
    $KB
    Commercial Banks
    Finance

    KB Financial upgraded by CLSA

    CLSA upgraded KB Financial from Outperform to Buy

    10/5/23 2:20:53 PM ET
    $KB
    Commercial Banks
    Finance

    $KB
    SEC Filings

    View All

    SEC Form 6-K filed by KB Financial Group Inc

    6-K - KB Financial Group Inc. (0001445930) (Filer)

    2/5/26 6:37:55 AM ET
    $KB
    Commercial Banks
    Finance

    SEC Form 6-K filed by KB Financial Group Inc

    6-K - KB Financial Group Inc. (0001445930) (Filer)

    2/5/26 6:36:27 AM ET
    $KB
    Commercial Banks
    Finance

    SEC Form 6-K filed by KB Financial Group Inc

    6-K - KB Financial Group Inc. (0001445930) (Filer)

    2/5/26 6:35:31 AM ET
    $KB
    Commercial Banks
    Finance

    $KB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Orum Therapeutics Secures Approximately US$100 Million to Accelerate Development of Leading Degrader Antibody Conjugate Programs to Treat Serious Diseases

    Funding supports advancing therapeutic programs toward clinical development, expanding discovery across novel payload classes to accelerate next-generation degrader-antibody conjugate (DAC) programs and broadening Orum's global capabilities and operations Participation from leading new investors and renewed commitment from long-time supporters signals strong confidence in Orum's scientific direction, providing a solid foundation for the company's next stage of growth and reinforcing Orum's position as a leader in next-generation DACs Orum Therapeutics ("Orum" or the "Company") (KRX: 475830), a public biotechnology company pioneering the field of degrader-antibody conjugates (DACs), tod

    12/18/25 3:25:00 AM ET
    $KB
    Commercial Banks
    Finance

    KB FINANCIAL GROUP INC. FILES ITS ANNUAL REPORT ON FORM 20-F

    SEOUL, South Korea, April 25, 2025 /PRNewswire/ -- On April 25, 2025, KB Financial Group Inc. filed its Annual Report on Form 20-F for the year ended December 31, 2024 with the U.S. Securities and Exchange Commission.  The 2024 Annual Report on Form 20-F can be downloaded from www.kbfg.com, as well as from the website of the U.S. Securities and Exchange Commission at www.sec.gov.  Investors may request a hard copy of the 2024 Annual Report on Form 20-F, free of charge, by contacting [email protected].  About KB Financial Group Inc. KB Financial Group is Korea's leading financial services provider, offering a broad range of financial products and services. The Group was founded in 2008 to bette

    4/25/25 7:58:00 AM ET
    $KB
    Commercial Banks
    Finance

    FriendliAI and Hugging Face Announce Strategic Partnership

    Developers will be able to utilize FriendliAI's accelerated generative AI infrastructure service to deploy and serve models in the Hugging Face HubREDWOOD CITY, Calif., Jan. 22, 2025 /PRNewswire/ -- FriendliAI, a leader in accelerated generative AI inference serving, and Hugging Face today announced a strategic partnership that allows developers to utilize FriendliAI's inference infrastructure service to deploy and serve models directly in the Hugging Face Hub. FriendliAI Endpoints, the fastest GPU-based generative AI inference provider according to Artificial Analysis, is now available as a deployment option on the Hugging Face platform. Directly from any model page on Hugging Face, develo

    1/22/25 10:00:00 AM ET
    $KB
    Commercial Banks
    Finance

    $KB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by KB Financial Group Inc (Amendment)

    SC 13G/A - KB Financial Group Inc. (0001445930) (Subject)

    2/9/24 1:39:48 PM ET
    $KB
    Commercial Banks
    Finance

    SEC Form SC 13G/A filed by KB Financial Group Inc (Amendment)

    SC 13G/A - KB Financial Group Inc. (0001445930) (Subject)

    2/3/22 4:29:37 PM ET
    $KB
    Commercial Banks
    Finance